Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethan Dmitrovsky

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Journal of Virology|December 16, 2014
MCL1 enhances the survival of CD8+ memory T Cells after viral infectionJingang Gui, Zhuting Hu, Ching-Yi Tsai, et al.
International Journal of Oncology|April 3, 2013
Repression of exogenous gene expression by the retinoic acid target gene G0S2Tian Ma, Jessica P Dong, David J Sekula, et al.
Cancer Research|February 4, 2016
G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional ProgramChristina Y Yim, David J Sekula, Mary P Hever-Jardine, et al.
Oncogene|August 2, 2003
Microarray analysis uncovers retinoid targets in human bronchial epithelial cellsYan Ma, Petra H Koza-Taylor, Debra A DiMattia, et al.
Cancer Research|March 17, 2007
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J miceKaren Liby, Darlene B Royce, Charlotte R Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomasYan Ma, Steven Fiering, Candice Black, et al.
Cancer Research Communications|July 14, 2022
Real-World Studies Link Nonsteroidal Anti-inflammatory Drug Use to Improved Overall Lung Cancer SurvivalJason Roszik, J Jack Lee, Yi-Hung Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastropheFabrizio Galimberti, Sarah L Thompson, Xi Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapyKonstantin H Dragnev, Ian Pitha-Rowe, Yan Ma, et al.
Molecular Cancer Therapeutics|July 4, 2012
Evidence for the ubiquitin protease UBP43 as an antineoplastic targetYongli Guo, Fadzai Chinyengetere, Andrey V Dolinko, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Journal of Virology|December 16, 2014
MCL1 enhances the survival of CD8+ memory T Cells after viral infectionJingang Gui, Zhuting Hu, Ching-Yi Tsai, et al.
International Journal of Oncology|April 3, 2013
Repression of exogenous gene expression by the retinoic acid target gene G0S2Tian Ma, Jessica P Dong, David J Sekula, et al.
Cancer Research|February 4, 2016
G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional ProgramChristina Y Yim, David J Sekula, Mary P Hever-Jardine, et al.
Oncogene|August 2, 2003
Microarray analysis uncovers retinoid targets in human bronchial epithelial cellsYan Ma, Petra H Koza-Taylor, Debra A DiMattia, et al.
Cancer Research|March 17, 2007
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J miceKaren Liby, Darlene B Royce, Charlotte R Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomasYan Ma, Steven Fiering, Candice Black, et al.
Cancer Research Communications|July 14, 2022
Real-World Studies Link Nonsteroidal Anti-inflammatory Drug Use to Improved Overall Lung Cancer SurvivalJason Roszik, J Jack Lee, Yi-Hung Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastropheFabrizio Galimberti, Sarah L Thompson, Xi Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapyKonstantin H Dragnev, Ian Pitha-Rowe, Yan Ma, et al.
Molecular Cancer Therapeutics|July 4, 2012
Evidence for the ubiquitin protease UBP43 as an antineoplastic targetYongli Guo, Fadzai Chinyengetere, Andrey V Dolinko, et al.
Pageof 9